Log in

NASDAQ:TGENTecogen Stock Price, Forecast & News

+0.02 (+2.84 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $0.73
50-Day Range
MA: $0.77
52-Week Range
Now: $0.73
Volume14,400 shs
Average Volume80,173 shs
Market Capitalization$18.04 million
P/E RatioN/A
Dividend YieldN/A
Tecogen Inc. designs, manufactures, and sells industrial and commercial cogeneration systems that produce combinations of electricity, hot water, and air conditioning in the United States and internationally. It operates through two segments, Products and Services and Energy Production. The company offers InVerde e+, a cogeneration product that provides electricity and hot water; TECOGEN cogeneration systems for producing hot water; TECOCHILL air-conditioning and refrigeration chillers; and water heaters under the Ilios brand name, as well as emissions control technology under Ultera brand name. It also provides long-term maintenance contracts, parts sales, and turnkey installation services through a network of nine field service centers in California, the Midwest, and the Northeast. In addition, the company installs, owns, operates, and maintains distributed generation of electricity systems and other complementary systems. It serves hospitals and nursing homes, colleges and universities, health clubs and spas, hotels and motels, office and retail buildings, food and beverage processors, multi-unit residential buildings, laundries, ice rinks, swimming pools, factories, municipal buildings, military installations, and indoor growing facilities. The company was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
Read More
Tecogen logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.11 out of 5 stars

Industry, Sector and Symbol

Industry Refrigeration & heating equipment
Current SymbolNASDAQ:TGEN



Sales & Book Value

Annual Sales$33.43 million
Cash Flow$0.09 per share
Book Value$0.94 per share


Net Income$-4,710,000.00


Market Cap$18.04 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable

Receive TGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for TGEN and its competitors with MarketBeat's FREE daily newsletter.

Tecogen (NASDAQ:TGEN) Frequently Asked Questions

How has Tecogen's stock been impacted by COVID-19 (Coronavirus)?

Tecogen's stock was trading at $1.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TGEN shares have decreased by 60.8% and is now trading at $0.7250. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Tecogen?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tecogen in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Tecogen.

When is Tecogen's next earnings date?

Tecogen is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Tecogen.

How were Tecogen's earnings last quarter?

Tecogen Inc. (NASDAQ:TGEN) posted its quarterly earnings results on Thursday, May, 14th. The construction company reported ($0.04) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.03. The construction company had revenue of $7.96 million for the quarter, compared to analysts' expectations of $9.33 million. Tecogen had a negative return on equity of 11.23% and a negative net margin of 7.92%. View Tecogen's earnings history.

What price target have analysts set for TGEN?

1 Wall Street analysts have issued 12 month target prices for Tecogen's stock. Their forecasts range from $4.50 to $4.50. On average, they expect Tecogen's stock price to reach $4.50 in the next year. This suggests a possible upside of 520.7% from the stock's current price. View analysts' price targets for Tecogen.

Has Tecogen been receiving favorable news coverage?

News headlines about TGEN stock have trended negative on Sunday, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Tecogen earned a media sentiment score of -2.6 on InfoTrie's scale. They also gave news articles about the construction company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Tecogen.

Are investors shorting Tecogen?

Tecogen saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 54,500 shares, an increase of 201.1% from the June 15th total of 18,100 shares. Based on an average daily volume of 148,400 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.4% of the company's stock are sold short. View Tecogen's Current Options Chain.

Who are some of Tecogen's key competitors?

What other stocks do shareholders of Tecogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tecogen investors own include Ring Energy (REI), Ring Energy (REI), Sorrento Therapeutics (SRNE), Biocept (BIOC), Eyepoint Pharmaceuticals (EYPT), NovaBay Pharmaceuticals (NBY), Sophiris Bio (SPHS), Veru (VERU), Weyerhaeuser (WY) and Agile Therapeutics (AGRX).

Who are Tecogen's key executives?

Tecogen's management team includes the following people:
  • Mr. Benjamin M. Locke, Chief Exec. Officer (Age 50)
  • Mr. Robert A. Panora, Pres & COO (Age 64)
  • Ms. Bonnie Jean Brown, Chief Accounting Officer, Principal Financial & Accounting Officer, Treasurer & Sec. (Age 55)
  • Mr. Joseph B. Gehret Jr., Chief Technology Officer
  • Ms. Ariel F. Babcock CFA, Director of Investor Relations

What is Tecogen's stock symbol?

Tecogen trades on the NASDAQ under the ticker symbol "TGEN."

How do I buy shares of Tecogen?

Shares of TGEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tecogen's stock price today?

One share of TGEN stock can currently be purchased for approximately $0.73.

How big of a company is Tecogen?

Tecogen has a market capitalization of $18.04 million and generates $33.43 million in revenue each year. The construction company earns $-4,710,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis.

What is Tecogen's official website?

The official website for Tecogen is www.tecogen.com.

How can I contact Tecogen?

Tecogen's mailing address is 45 FIRST AVENUE, WALTHAM MA, 02451. The construction company can be reached via phone at 781-466-6402 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.